NAMITA THAPAR EMCURE
Shark Tank's Namita Thapar's strong message to top bosses on how to treat juniors: Stop competing, start coaching
Namita Thapar shares a poem about leadership. The poem uses trees as metaphors. It shows the value of old and new ideas. The poem highlights generational differences in the workplace. It encourages coaching over competition. Social media users reacted positively to the poem. They found it relatable and comforting. The poem promotes collaboration between generations.
Hotmail founder Sabeer Bhatia indirectly roasts Shark Tank India judges after Namrata Thapar calls him out
Hotmail co-founder Sabeer Bhatia reignited a public debate on India’s startup ecosystem by urging investors to support bold, disruptive ideas instead of easy-to-scale delivery startups. His comments, made on social media, appeared to be a subtle response to Shark Tank India judge Namita Thapar, who had earlier criticised Bhatia for questioning the work ethic of Indian engineers. The exchange sparked mixed reactions online, with some supporting Bhatia’s call for deeper innovation and others defending the practicality of current startup models.
Shark Tank contestant Aquapeya asked to stop selling water brand by Court
Packaged water brand Aquapeya, funded by Shark Tank’s Namita Thapar and Ritesh Agarwal, has been ordered by the Bombay High Court to halt operations after Bisleri International accused it of trademark and copyright infringement. The accusation followed Aquapeya’s admissions on the show about benefiting from the market goodwill of established brands.
Rs 600 crore Shark Tank judge was mocked for weight and called ‘girl with moustache’ in school, opens up about being bullied
Namita Thapar, Executive Director of Emcure Pharmaceuticals and Shark Tank India judge, revealed her childhood bullying experiences, including being nicknamed the 'moustache girl'. She addressed the broader issue of bullying and shared her struggles with body image and emotional eating. Namita's hope for evolving societal norms highlights the importance of addressing such issues for future generations.
Shark Tank India 4: Anupam Mittal salutes CEO of beauty brand which has incurred loss of Rs 2.5 crore
The fourth season of Shark Tank India, premiering January 6, promises inspiring entrepreneurial stories. Among the standout participants is Karishma Kewalramani, founder of Fae Beauty, an inclusive brand. Despite substantial losses, she seeks ₹1 crore for 1% equity, showcasing determination and a bold vision for reshaping the beauty industry.
Namita Thapar challenges Narayana Murthy's advice, says those who make 'tons of money' can go for longer working hours
Shark Tank India judges Namita Thapar and Anupam Mittal, in a fiery debate on work-life balance, clashed over the concept of a 70-hour workweek. Mittal, founder of Shaadi.com, argued that working long hours is essential for achieving extraordinary success, citing his own experience. Thapar, Executive Director at Emcure Pharmaceuticals, disagreed, stressing that founders may have the incentive to work long hours but regular employees should not be expected to do the same due to health and family implications.
- Go To Page 1
Emcure Pharma brings product range for menopause wellness
Emcure Pharmaceuticals has introduced the Arth range of products to support women during menopause. This new line aims to alleviate symptoms such as hot flashes, night sweats, mood swings, and vaginal dryness. The company emphasizes raising awareness and providing affordable solutions for women's health during this critical phase.
Shark tank fame Namita Thapar shares an emotional Mirza Ghalib shayari post Emcure IPO's robust listing
The robust listing met expectations, reflecting the company's long-term potential. Analysts recommend that investors maintain their positions for promising future returns.
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?
Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Thapar to earn Rs 127 crore through the stake sale. The company targets debt repayment and global expansion.
Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO
Shark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the upcoming IPO. Thapar, who acquired shares in Emcure at an average price of Rs 3.44 each, will sell around 12.68 lakh shares through the OFS component of the IPO. With the upper price band set at Rs 1,008 per share, the stake sale is expected to yield about Rs 127 crore.
IPO Analysis: Emcure has better-listed pharma alternatives
Emcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors like HDFC Mutual Fund and ICICI Prudential Mutual Fund, showcasing immense market confidence in its upcoming IPO.
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription
Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.
‘Shark Tank India’ judge Namita Thapar silences trolls who claimed she succeeded with ‘daddy’s money’
The entrepreneur, who recently held an ‘Ask Me Anything’ session on Reddit, was initially taken aback when a Reddit user attacked her personally, stating that she would be nowhere without the support of her father Satish Mehta, the founder of Emcure Pharmaceuticals.
'Shark Tank India' judge Namita Thapar candidly opens up about perimenopause struggles during show: Watch
Namita Thapar, the executive director of Emcure Pharmaceuticals and a judge on Shark Tank India, recently shared her personal struggles with perimenopause during an episode of the show. She spoke openly about experiencing heavy bleeding and discomfort, leading to anaemia. Thapar's candid disclosure prompted widespread support and dialogue on social media, highlighting the importance of destigmatizing discussions surrounding women's health.
Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fame
Shark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February 10 that the company plans to go public within three months.
'Shark Tank India' gears up for season 3 with new 'Sharks'; Zomato chief Deepinder Goyal, OYO boss Ritesh Agarwal join jury
The shooting of the third season of 'Shark Tank India' has already begun! Let's meet the news 'Sharks' in town.
Shark Tank judge Namita Thapar talks about her struggles with IVF, says 'I gave up, took 25 Injections'
In that particular episode, the pitch presented by the contestant focused on the issue of infertility that women face, and that's when Namita talked about her struggles.
Shark Tank India 2: Over Rs 42 crore in investment so far, Namita Thapar leads the race
Shark Tank India 2 has received an investment of Rs. 42.93 crore after five weeks, with Namita Thapar, Peyush Bansal, and Aman Gupta leading the way.
'Hire people smarter than you.' Namita Thapar reveals her leadership mantra
She also highlighted the importance of less being more.
Namita Thapar organises 'Top Gun: Maverick' screening for 200 Emcure employees, shares leadership lessons from the movie
The desi Shark held the special screen for her staff to drive away Monday blues.
Namita Thapar makes up for her ‘regret’ move in ‘Shark Tank India’ show, invests in farmer Pandurang Taware's start-up
Thapar revealed that her two regrets were 'jugaadu Kamlesh' and Pandurang Taware.
Namita Thapar says yoga and meditation made her a 'better' person, increased productivity
The Emcure Pharma ED urged everyone to explore this 'calmer' way of life.
TagZ Foods raises funds from BharatPe's Ashneer Grover, others
TagZ Foods plans to use the funds to expand its product line, production capacity and strengthen its distribution to other cities.
Covid-19 has pushed us to have more meaningful get-togethers, says Emcure Pharmaceutical ED
Namita Thapar feels the pandemic shouldn't stop us from being with loved ones.
Emcure Pharma boss's NY resolution: Mastering meditation, sitting quietly & doing nothing
As daunting as the prospect is, Namita Thapar is hopeful she can achieve it.
Women need to ask for help, not permission: Namita Thapar
Things changed for Thapar when she became a mother.
ET Women's Forum: #MeToo created empathy, brought change at the workplace
The #MeToo campaign has helped accelerate a cultural change.
ET 40 Under Forty: When corporate big bosses looked sharper than their suits
The entrepreneurial stars brought to the power room an interesting mix of classic staples and bold accessories.
Load More
